東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Modeling the Transfer of Drug Resist...

Becker, Matthew Harrington.

FindBook

Google Book

Amazon

博客來

Modeling the Transfer of Drug Resistance in Solid Tumors.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Modeling the Transfer of Drug Resistance in Solid Tumors./
作者:	Becker, Matthew Harrington.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
面頁冊數:	121 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-01, Section: B.
Contained By:	Dissertations Abstracts International80-01B.
標題:	Applied Mathematics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10787648
ISBN:	9780438153820

Modeling the Transfer of Drug Resistance in Solid Tumors.
Becker, Matthew Harrington.

Modeling the Transfer of Drug Resistance in Solid Tumors. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 121 p.

Source: Dissertations Abstracts International, Volume: 80-01, Section: B.

Thesis (Ph.D.)--University of Maryland, College Park, 2018.

This item is not available from ProQuest Dissertations & Theses.

ABC efflux transporters are a key factor leading to multidrug resistance in cancer. Overexpression of these transporters significantly decreases the efficacy of anti-cancer drugs. Along with selection and induction, drug resistance may be trans- ferred between cells, which is the focus of this dissertaion. Specifically, we consider the intercellular transfer of P-glycoprotein (P-gp), a well-known ABC transporter that was shown to confer resistance to many common chemotherapeutic drugs. In a recent paper, Duran et al. studied the dynamics of mixed cultures of resistant and sensitive NCI-H460 (human non-small cell lung cancer) cell lines. As expected, the experimental data showed a gradual increase in the percentage of resistance cells and a decrease in the percentage of sensitive cells. The experimental work was accompanied with a mathematical model that assumed P-gp transfer from resistant cells to sensitive cells, rendering them temporarily resistant. The mathematical model provided a reasonable fit to the experimental data. In this dissertation we develop three new mathematical model for the transfer of drug resistance between cancer cells. Our first model is based on incorporating a resistance phenotype into a model of cancer growth. The resulting model for P-gp transfer, written as a system of integro-differential equations, follows the dynamics of proliferating, quiescent, and apoptotic cells, with a varying resistance phenotype. We show that this model provides a good match to the dynamics of the experimental data of. The mathematical model further suggests that resistant cancer cells have a slower division rate than the sensitive cells. Our second model is a reaction-diffusion model with sensitive, resistant, and temporarily resistant cancer cells occupying a 2-dimensional space. We use this model as another extension of Duran et al.. We show that this model, with competition and diffusion in space, provides an even better fit to the experimental data. We incorporate a cytotoxic drug and study the effects of varying treatment protocols on the size and makeup of the tumor. We show that constant infusion leads to a small but highly resistant tumor, while small doses do not do enough to control the overall growth of the tumor. Our final model extends Magal, et al., an integro-differential equation with resistance modeled as a continuous variable and a Boltzmann type integral describing the transfer of P-gp expression. We again extend the model into a 2-dimensional spatial domain and incorporate competition inhibited growth. The resulting model, written as a single partial differential equation, shows that over time the resistance transfer leads to a uniform distribution of resistance levels, which is consisten with the results of Magal, et al. We include a cytotoxic agent and determine that, as with our second model, it alone cannot successfully eradicate the tumor. We briefly present a second extension wherein we include two distinct transfer rules. We show that there is no qualitative difference between the single transfer rule and the two-transfer rule model.

ISBN: 9780438153820Subjects--Topical Terms:

1669109
Applied Mathematics.
Subjects--Index Terms:

Cancer

Modeling the Transfer of Drug Resistance in Solid Tumors.
LDR:04476nmm a2200421 4500 001 2267571
005 20200724103001.5
008 220629s2018 ||||||||||||||||| ||eng d
020 $a 9780438153820
035 $a (MiAaPQ)AAI10787648
035 $a (MiAaPQ)umd:18863
035 $a AAI10787648
040 $a MiAaPQ $c MiAaPQ
100 1 $a Becker, Matthew Harrington. $3 3544826
245 1 0 $a Modeling the Transfer of Drug Resistance in Solid Tumors.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 121 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-01, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Levy, Doron.
502 $a Thesis (Ph.D.)--University of Maryland, College Park, 2018.
506 $a This item is not available from ProQuest Dissertations & Theses.
506 $a This item must not be sold to any third party vendors.
520 $a ABC efflux transporters are a key factor leading to multidrug resistance in cancer. Overexpression of these transporters significantly decreases the efficacy of anti-cancer drugs. Along with selection and induction, drug resistance may be trans- ferred between cells, which is the focus of this dissertaion. Specifically, we consider the intercellular transfer of P-glycoprotein (P-gp), a well-known ABC transporter that was shown to confer resistance to many common chemotherapeutic drugs. In a recent paper, Duran et al. studied the dynamics of mixed cultures of resistant and sensitive NCI-H460 (human non-small cell lung cancer) cell lines. As expected, the experimental data showed a gradual increase in the percentage of resistance cells and a decrease in the percentage of sensitive cells. The experimental work was accompanied with a mathematical model that assumed P-gp transfer from resistant cells to sensitive cells, rendering them temporarily resistant. The mathematical model provided a reasonable fit to the experimental data. In this dissertation we develop three new mathematical model for the transfer of drug resistance between cancer cells. Our first model is based on incorporating a resistance phenotype into a model of cancer growth. The resulting model for P-gp transfer, written as a system of integro-differential equations, follows the dynamics of proliferating, quiescent, and apoptotic cells, with a varying resistance phenotype. We show that this model provides a good match to the dynamics of the experimental data of. The mathematical model further suggests that resistant cancer cells have a slower division rate than the sensitive cells. Our second model is a reaction-diffusion model with sensitive, resistant, and temporarily resistant cancer cells occupying a 2-dimensional space. We use this model as another extension of Duran et al.. We show that this model, with competition and diffusion in space, provides an even better fit to the experimental data. We incorporate a cytotoxic drug and study the effects of varying treatment protocols on the size and makeup of the tumor. We show that constant infusion leads to a small but highly resistant tumor, while small doses do not do enough to control the overall growth of the tumor. Our final model extends Magal, et al., an integro-differential equation with resistance modeled as a continuous variable and a Boltzmann type integral describing the transfer of P-gp expression. We again extend the model into a 2-dimensional spatial domain and incorporate competition inhibited growth. The resulting model, written as a single partial differential equation, shows that over time the resistance transfer leads to a uniform distribution of resistance levels, which is consisten with the results of Magal, et al. We include a cytotoxic agent and determine that, as with our second model, it alone cannot successfully eradicate the tumor. We briefly present a second extension wherein we include two distinct transfer rules. We show that there is no qualitative difference between the single transfer rule and the two-transfer rule model.
590 $a School code: 0117.
650 4 $a Applied Mathematics. $3 1669109
650 4 $a Mathematics. $3 515831
650 4 $a Biomedical engineering. $3 535387
650 4 $a Oncology. $3 751006
653 $a Cancer
653 $a Differential equations
653 $a Drug resistance
653 $a Mathematical modeling
653 $a P-glycoprotein
690 $a 0364
690 $a 0405
690 $a 0541
690 $a 0992
710 2 $a University of Maryland, College Park. $b Applied Mathematics and Scientific Computation. $3 1021743
773 0 $t Dissertations Abstracts International $g 80-01B.
790 $a 0117
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10787648